Perlegen to Mine 4 Million Patient Records for Predictive Markers | GenomeWeb
This article has been corrected to note that Perlegen is a spinout of Affymetrix, not a subsidiary as previously reported.
 
NEW YORK (GenomeWeb News) – Perlegen Sciences said today it will work with an undisclosed electronic medical records company to search through data from four million patients for genetic markers that could help predict patient response to certain medical treatments.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.